Guaifenesin Tablet, Extended Release
Product Images NDC 69848-018

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 69848-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

14 Count (200000002973 R 00 Final)

14 Count (200000002973 R 00 Final)
This is a description of a medication named Guaifenesin, which is an extended-release tablet that comes in 1200 mg strength. It claims to relieve chest congestion by thinning and loosening mucus with immediate and extended release. It consists of bi-layer tablets and is compared to the active ingredient of Maximum Strength Mucinex. It is advised to ask a doctor before use if one has a chronic cough, asthma, bronchitis, and other respiratory disorders. The medication comes with specific directions and precautionary instructions, and one should contact medical professionals if they experience serious coughing symptoms with a fever, rash, or persistent headache. Inactive ingredients are also mentioned in the provided text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.